Covering the last 90 days

Biology

Biology on Scoop.it is moving between the lab, the clinic and the field. Recent selections follow immune responses, engineered genomes, plant-microbe partnerships, cancer cell analysis, neuroinflammation, rainforest biodiversity, zoology and classroom biology resources.

The subject area is fed by 36 curators across 64 topics, with 216 posts in the corpus from the last 90 days. The most quoted sources include Nature, LinkedIn, ScienceDirect, Frontiers, Springer, Science, Cell, Wiley and MDPI, which gives the page a mix of primary research, professional commentary and teaching material.

What is moving now is the translation of biological mechanisms into usable systems. Symbiosis is treated as a crop trait, genome editing as a therapeutic platform, immunity as a tissue-specific response, and cancer biology as a cell-by-cell diagnostic problem.

Key figures

  • 64 topics
  • 36 curators
  • 3009470 views
  • November 13, 2026 last activity

Cross-cutting issues

1

Engineered biology is leaving the workbench for living systems

As genome editors, synthetic assemblies and delivery vehicles approach real applications, reliability becomes the central biological question.

Programmable design of functional proteins from natural language nature.com

Synthetic Biology brings the most explicit shift from parts to programs. Recent selections on functional protein design from natural language and bottom-up RNA transfer vehicles treat engineered biology as a design discipline, but the biological question remains whether the constructs behave predictably inside living systems.

Genetic Engineering Publications adds the therapeutic pressure test. A base-editing study in a mouse model of Hutchinson-Gilford progeria syndrome and reports on in vivo CRISPR therapy show editing moving closer to patients, where delivery, dose, off-target activity and durability matter as much as molecular elegance.

RMH and I2BC Paris-Saclay widen the frame beyond standard tool papers. An engineered CasX editor points to optimization for therapeutic use, while CRISPR-Cas12a editing in a non-model cyanobacterium shows the same reliability problem in microbial systems that are harder to domesticate.

Across these topics, the story is no longer simply that genomes can be rewritten. The harder question is how to make edits, transfers and synthetic assemblies controllable enough for medicine, microbiology and future biological production.

Further reading

2

Vaccines and infections are being read through barriers and transfer

The immune response now looks less like a single systemic reaction and more like a set of tissue, microbiome and life-stage effects.

Why immune responses to vaccines vary from person to person | ASU News news.asu.edu

Virology News and Immunology and Biotherapies meet around a basic observation: vaccine responses are not uniform. Posts on person-to-person variation in vaccine response and a microbiome link to vaccination place immune performance inside a broader biological context rather than treating it as a simple yes-or-no outcome.

Mucosal Immunity adds the barrier tissues where many infections begin. Respiratory antibodies in influenza, SARS-CoV-2 and RSV coverage point to the lungs as an active immune site, while a study of H5N1 transmission through placental and mammary routes brings maternal-fetal biology into the same discussion.

The same thread runs through selections on breastfeeding and viral infections in preterm infants. Protection is framed through transfer, timing and tissue context, not only through later vaccination schedules or circulating antibodies.

This reframing matters for clinical immunology because it links vaccines, microbiomes, respiratory surfaces, pregnancy and infant development. The topics converge on immune responses as local, developmental and disease-specific, not as one generic system.

Further reading

3

Cancer diagnosis and therapy are converging around single cells

Liquid biopsy, circulating tumor cells and immune profiling are becoming parts of the same precision-oncology workflow.

#liquidbiopsy #ctdna #cancerresearch #precisiononcology #aiinhealthcare #oncology #futureofoncology | Liquid Biopsy linkedin.com

from Flow Cytometry to Cytomics and NANCYTOMIQUE connect diagnosis to cell behavior. Posts on liquid biopsy, circulating tumor cells and tumor-cell clusters show cancer being followed through rare cells and fragments in blood, not only through tissue taken at diagnosis.

The same cell-centered view reaches metastatic sites. A multiomic analysis of malignant ascites identifies immune-cell states at sites of spread, while zebrafish imaging of breast cancer cells leaving the bloodstream turns dissemination into an observable biological process.

AUTOIMMUNITY adds an important caution: immune signatures can explain severe disease outside oncology too. A post on autoantibodies neutralizing type I interferons in Chikungunya encephalitis or myelitis shows how cell and antibody profiling can identify mechanisms that change clinical risk.

Together, these topics place cytometry, liquid biopsy, circulating tumor cells, immune profiling and rare-event detection in one pipeline. The promise is earlier and more precise diagnosis; the challenge is turning complex cell signals into decisions that clinicians can trust.

Further reading

Curators to follow

  • Gilbert C FAURE

    Follows immunology, neuroimmunology, mucosal immunity, allergy, cytometry and cancer cell biology across several active topics.

  • BigField GEG Tech

    Selects genetic engineering publications, animal model work and genome-editing applications, with emphasis on disease models and delivery.

  • Ed Rybicki

    Tracks virology news, vaccine response, infectious disease studies and immune mechanisms in human pathogens.

  • Jean-Michel Ané

    Gathers detailed plant-microbe symbiosis research, from root exudates and nodulation to mycorrhizal function and crop matching.

  • Serenella A Sukno

    Follows Colletotrichum research, including plant disease, fungal pathogenicity and resistance to fungicides.

  • mhryu@live.com

    Highlights microbiology and genome-editing papers, including CRISPR therapy and editor-engineering work.

  • I2BC Paris-Saclay

    Tracks cell and molecular biology from I2BC Paris-Saclay, including genome editing in non-model organisms.

  • Gerd Moe-Behrens

    Selects synthetic biology research on programmable proteins, RNA transfer vehicles and engineered biological systems.

Frequently asked questions

What biology topics are covered here?

The page spans molecular biology, immunology, microbiology, plant sciences, ecology, zoology, synthetic biology, diagnostics and cancer research. It also includes classroom resources, veterinary and animal model material, and biology networks. The mix comes from specialized Scoop.it topics rather than from a single editorial beat.

How current is the biology material on this page?

This reference page is based on material from the last 90 days. The subject area includes 64 topics, 36 curators and 216 posts in the corpus, with the latest activity on 2026-11-13. It is designed to show what has been actively selected recently.

Why is plant-microbe biology so visible here?

Plant-microbe work is prominent because several topics follow symbiosis, plant disease, root biology, crop resilience and pathogen genomics. Recent selections focus on root exudates, rhizobia, mycorrhizal fungi, nodulation and fungal plant pathogens, linking basic plant biology to crop performance and disease management.

What kind of immunology coverage can I expect?

Immunology appears through several connected topics: clinical immunology, mucosal immunity, autoimmunity, neuroimmunology, virology and cancer cell analysis. The recent material emphasizes vaccine response, microbiome effects, respiratory barriers, maternal transfer, immune-cell profiling and autoantibodies, so immune biology cuts across infection, cancer and neurological disease.

Are these mostly research papers or general biology news?

Many selections point to primary research or research-facing sources, including Nature, ScienceDirect, Frontiers, Science, Wiley and Cell. The page also includes news explainers, professional posts and teaching resources, so readers should expect a mix of journal articles, summaries and educational material.

How should teachers and researchers use this page?

Teachers can use the page to find classroom examples from wildlife, genetics, ecology and human biology. Researchers can scan it for cross-field signals, such as genome editing moving toward therapy, plant symbiosis becoming measurable, and immune responses being interpreted through tissue barriers and microbiomes.

Most quoted sources

  • nature.com 13
  • linkedin.com 7
  • sciencedirect.com 5
  • frontiersin.org 5
  • link.springer.com 4
  • science.org 4
  • cell.com 4
  • facebook.com 4
  • onlinelibrary.wiley.com 3
  • mdpi.com 3

This page was written by an AI from the public curation of Scoop.it topics. The posts, topics and curators it cites are real and linked directly.

Updated on November 13, 2026